246 related articles for article (PubMed ID: 25689063)
1. Significance of tumour cell HLA-G5/-G6 isoform expression in discrimination for adenocarcinoma from squamous cell carcinoma in lung cancer patients.
Yan WH; Liu D; Lu HY; Li YY; Zhang X; Lin A
J Cell Mol Med; 2015 Apr; 19(4):778-85. PubMed ID: 25689063
[TBL] [Abstract][Full Text] [Related]
2. Lesion HLA-G5/-G6 isoforms expression in patients with ovarian cancer.
Zhang X; Han QY; Li JB; Ruan YY; Yan WH; Lin A
Hum Immunol; 2016 Sep; 77(9):780-4. PubMed ID: 26687271
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis.
Zheng J; Xu C; Chu D; Zhang X; Li J; Ji G; Hong L; Feng Q; Li X; Wu G; Du J; Zhao Q
Immunol Lett; 2014 Sep; 161(1):13-9. PubMed ID: 24768599
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.
Lin A; Zhu CC; Chen HX; Chen BF; Zhang X; Zhang JG; Wang Q; Zhou WJ; Hu W; Yang HH; Xu HH; Yan WH
J Cell Mol Med; 2010 Sep; 14(9):2318-29. PubMed ID: 19602033
[TBL] [Abstract][Full Text] [Related]
5. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
6. High levels of soluble MICA are significantly related to increased disease-free and disease-specific survival in patients with cervical adenocarcinoma.
Samuels S; Ferns DM; Meijer D; van Straalen JP; Buist MR; Zijlmans HJ; Kenter GG; Jordanova ES
Tissue Antigens; 2015 Jun; 85(6):476-83. PubMed ID: 25871737
[TBL] [Abstract][Full Text] [Related]
7. Human Leukocyte Antigen G Polymorphism and Expression Are Associated with an Increased Risk of Non-Small-Cell Lung Cancer and Advanced Disease Stage.
Ben Amor A; Beauchemin K; Faucher MC; Hamzaoui A; Hamzaoui K; Roger M
PLoS One; 2016; 11(8):e0161210. PubMed ID: 27517300
[TBL] [Abstract][Full Text] [Related]
8. Human leukocyte antigen-G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma.
Lin A; Zhang X; Zhou WJ; Ruan YY; Xu DP; Wang Q; Yan WH
Int J Cancer; 2011 Sep; 129(6):1382-90. PubMed ID: 21128238
[TBL] [Abstract][Full Text] [Related]
9. Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
Kirana C; Ruszkiewicz A; Stubbs RS; Hardingham JE; Hewett PJ; Maddern GJ; Hauben E
Int J Cancer; 2017 Jun; 140(11):2577-2586. PubMed ID: 28233298
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients.
Schütt P; Schütt B; Switala M; Bauer S; Stamatis G; Opalka B; Eberhardt W; Schuler M; Horn PA; Rebmann V
Hum Immunol; 2010 May; 71(5):489-95. PubMed ID: 20156510
[TBL] [Abstract][Full Text] [Related]
11. Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling.
Zhang Y; Zhao J; Qiu L; Zhang P; Li J; Yang D; Wei X; Han Y; Nie S; Sun Y
Tumour Biol; 2016 Aug; 37(8):11187-98. PubMed ID: 26939901
[TBL] [Abstract][Full Text] [Related]
12. Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.
Rebmann V; Lemaoult J; Rouas-Freiss N; Carosella ED; Grosse-Wilde H
Hum Immunol; 2005 Aug; 66(8):853-63. PubMed ID: 16216668
[TBL] [Abstract][Full Text] [Related]
13. Loss of β-arrestin1 expression predicts unfavorable prognosis for non-small cell lung cancer patients.
Ma H; Wang L; Zhang T; Shen H; Du J
Tumour Biol; 2016 Jan; 37(1):1341-7. PubMed ID: 26293896
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma.
Vermylen P; Roufosse C; Burny A; Verhest A; Bosschaerts T; Pastorekova S; Ninane V; Sculier JP
Eur Respir J; 1999 Oct; 14(4):806-11. PubMed ID: 10573225
[TBL] [Abstract][Full Text] [Related]
15. [Clinical significance of syndecan-1 and syndecan-2 expression in gallbladder squamous cell/adenosquamous carcinoma and adenocarcinoma].
Tan XG; Yang ZL; Miao XY; Liu ZR; Li DQ; Zou Q; Li JH; Liang LF
Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):28-34. PubMed ID: 29365414
[No Abstract] [Full Text] [Related]
16. Detection of serum soluble HLA-G levels in patients with acute ischemic stroke: A pilot study.
Fainardi E; Bortolotti D; Castellazzi M; Casetta I; Bellini T; Rizzo R
Hum Immunol; 2020 Apr; 81(4):156-161. PubMed ID: 31735441
[TBL] [Abstract][Full Text] [Related]
17. Characterization of HLA-G expression in renal cell carcinoma.
Li BL; Lin A; Zhang XJ; Zhang X; Zhang JG; Wang Q; Zhou WJ; Chen HX; Wang TJ; Yan WH
Tissue Antigens; 2009 Sep; 74(3):213-21. PubMed ID: 19531101
[TBL] [Abstract][Full Text] [Related]
18. Correlation between FDG-PET/CT findings and solid type non-small cell cancer prognostic factors: are there differences between adenocarcinoma and squamous cell carcinoma?
Ito R; Iwano S; Kishimoto M; Ito S; Kato K; Naganawa S
Ann Nucl Med; 2015 Dec; 29(10):897-905. PubMed ID: 26342592
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of high circulating sHLA-G in ovarian carcinoma.
Babay W; Boujelbene N; Ben Yahia H; Bortolotti D; Zemni I; Ouzari HI; Chelbi H; Mezlini A; Rizzo R; Zidi I
HLA; 2021 Oct; 98(4):357-365. PubMed ID: 34272932
[TBL] [Abstract][Full Text] [Related]
20. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]